在日本早期发病的帕金森病中鉴定DAGLB变异
Yue Luo1, Manabu Funayama2,3,4, Taku Hatano1
1Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Journal of neural transmission (Vienna, Austria : 1996)
|April 17, 2025
概括
甲基糖醇脂酶β (DAGLB) 基因中的遗传变异与早期发病的帕金森病 (EOPD) 有关. 这项研究在日本EOPD患者中发现了一种致病性DAGLB变体,证实了它在疾病中的作用.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 遗传因素显著影响帕金森病 (PD) 的发展.
- 甲基糖醇脂酶β (DAGLB) 的双变体与中国和阿尔及利亚人群中早期发病的帕金森病 (EOPD) 有关.
- 之前在日本患者中没有报告过DAGLB变异的EOPD病例.
研究的目的:
- 在日本患者中调查DAGLB变异的发生,这些患者有零星的EOPD和可疑的自体逆向性PD (ARPD).
- 为了确定DAGLB中的功能丧失变异是否有助于日本人口中的EOPD.
主要方法:
- 对270名零星EOPD患者和276名ARPD患者进行查.
- 使用桑格测序对DAGLB基因的所有编码前子和侧边拼接区域的基因分析.
- 罕见双变异的识别和表征.
主要成果:
- 在来自血缘亲属家庭的两名患者中,发现了两种罕见的双形DAGLB变体.
- 发现了一种致病性同卵性框架转移变体 (c.1770_1771del,p.Tyr591ProfsTer26).
- 一个错误的变异 (c.1444T>C,p.Tyr482His) 被确定,但预测是良性的,并排除了同隔离.
结论:
- 在日本EOPD患者中发现了DAGLB基因的致病变体.
- 这些发现支持了DAGLB功能丧失变体在日本人口中EOPD病变发生中的作用.
- 这扩大了EOPD已知的遗传谱,并突出了DAGLB作为不同种族群体的相关基因.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.4K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.3K
相关概念视频
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Parkinson's Disease: Overview
311
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
311
Parkinson's Disease: Treatment
152
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
152
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
